Copyright and Trademark Issues in the Pharmaceutical Industry: Generic Compliance or Brand Drug Imitating: 'Copycat or Compliance'

Pennsylvania Bar Association Quarterly, January 2013

13 Pages Posted: 6 Feb 2013

See all articles by Roseann B. Termini

Roseann B. Termini

Widener University Delaware Law School

Amy Miele

Widener University

Date Written: February 5, 2013

Abstract

Imitation is the sincerest form of flattery; that is, unless the imitation is of a product produced by a multi billion-dollar industry. Then, imitation has the potential to involve intellectual property litigation. For the pharmaceutical industry, the majority of intellectual property litigation stems from the interplay between generic or imitator drug and brand name or pioneer drug manufacturers.

Keywords: copyright, trademark, pharmaceutical industry, intellectual property, generic drugs

JEL Classification: K23, K32

Suggested Citation

Termini, Roseann B. and Miele, Amy, Copyright and Trademark Issues in the Pharmaceutical Industry: Generic Compliance or Brand Drug Imitating: 'Copycat or Compliance' (February 5, 2013). Pennsylvania Bar Association Quarterly, January 2013, Available at SSRN: https://ssrn.com/abstract=2212473

Roseann B. Termini (Contact Author)

Widener University Delaware Law School ( email )

4601 Concord Pike
Wilmington, DE 19803-0406
United States

Amy Miele

Widener University ( email )

3800 Vartan Way
PO Box 69381
Harrisburg, PA 17106-9381
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
1,788
Abstract Views
5,975
Rank
17,789
PlumX Metrics